Simultaneous Quantification of a Novel β‐Carboline Alkaloid Derivative and Its Three Metabolites in Rat Plasma by UHPLC‐MS/MS and Its Application to a Pharmacokinetic Study
Journal of Separation Science · 2025
DOI: 10.1002/jssc.70282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Separation Science, 2025. Verfasst von Mireyi Bahatijiang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Carbolines, Alkaloids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Key Project of the Natural Science Foundation of Xinjiang Uygur Autonomous Region, National Natural Science Foundation of China.
Abstract (Originalsprache)
1‐Methyl‐9‐(3‐pyridinylmethyl)‐9H‐pyrido[3,4‐b] indole (HMYB) is a novel semi‐synthetic alkaloid derived from β‐carboline harmane, which has been proven to be effective in treatment of encopresis. But the pharmacokinetic characteristics of HMYB were not yet illustrated. In this study, three metabolites (harmane, harmol, and 7‐OH‐HMYB) of HMYB were isolated from rat urine after oral administration of HMYB and authenticated with nuclear magnetic resonance spectroscopy and high‐resolution mass spectrometry. Most significantly, HMYB and its three metabolites were simultaneously quantified accurately in rat plasma using a quick, sensitive and selective UHPLC‐MS/MS method. On an ACQUITY UPLC BEH C18 column (2.1 × 50 mm, 1.7 µm), the analytes and internal standard (osalmid) were separated by gradient elution using acetonitrile and water containing 0.1% formic acid at a flow rate of 0.4 mL/min. The mass spectrometry detector was used in positive ionization mode for multiple reaction monitoring. The method showed good linearity over the concentration range of 0.5–500 ng/mL for HMYB and three metabolites. The method was applied to the pharmacokinetic study of HMYB and its three metabolites after oral doses of HMYB (25, 50, and 100 mg/kg) and intravenous administration of 0.5 mg/kg in rats. Pharmacokinetic differences between HMYB and its three metabolites were determined, along with the absolute bioavailability of HMYB. These results would be helpful in understanding the efficacy of HMYB. The results will also contribute to providing guidance for the structural modification of more effective semi‐synthetic derivatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Pharmaceutical Department, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
- College of Pharmacy, Xinjiang Medical University, Urumqi, Xinjiang, China.
Förderung
- Key Project of the Natural Science Foundation of Xinjiang Uygur Autonomous Region
- National Natural Science Foundation of China
Zitieren
APA
Bahatijiang, M., Xu, N., Hu, X., Liu, W., Lei, J., Zhang, S., Cai, F., Xie, Z., Zhou, M., Wang, J., Gao, H., Teng, L., Guan, H., & Wang, C. (2025). Simultaneous Quantification of a Novel β‐Carboline Alkaloid Derivative and Its Three Metabolites in Rat Plasma by UHPLC‐MS/MS and Its Application to a Pharmacokinetic Study. Journal of Separation Science. https://doi.org/10.1002/jssc.70282
Vancouver
Bahatijiang M, Xu N, Hu X, Liu W, Lei J, Zhang S, et al. Simultaneous Quantification of a Novel β‐Carboline Alkaloid Derivative and Its Three Metabolites in Rat Plasma by UHPLC‐MS/MS and Its Application to a Pharmacokinetic Study. Journal of Separation Science. 2025. doi:10.1002/jssc.70282
BibTeX
@article{Bahatijiang2025,
author = {Bahatijiang, Mireyi and Xu, Nan and Hu, Xianrun and Liu, Wenkang and Lei, Jinchun and Zhang, Sitong and Cai, Fujie and Xie, Zhejun and Zhou, Maojie and Wang, Junyi and Gao, Huijing and Teng, Liang and Guan, Huida and Wang, Changhong},
title = {Simultaneous Quantification of a Novel β‐Carboline Alkaloid Derivative and Its Three Metabolites in Rat Plasma by UHPLC‐MS/MS and Its Application to a Pharmacokinetic Study},
journal = {Journal of Separation Science},
year = {2025},
doi = {10.1002/jssc.70282}
}
EUVIMED